News

DS Group completes acquisition of Meditech International

TORONTO, Oct. 22, 2024 (GLOBE NEWSWIRE) – DS Group, a creative, entrepreneurial, unique, high-performance firm serving entrepreneurs of small and medium-sized businesses, is proud to announce that it has completed the acquisition of Meditech International Inc. The transaction closed on July 31st, 2024.

Meditech International was founded in 1993 by Dr Fred Khan, a pioneering vascular surgeon who innovated low energy laser therapy as an alternative to traditional medical interventions. Meditech International is a technology leader in low power laser therapy with global presence. Meditech International also operates a world-renowned laser therapy clinic treating thousands of patients with their BIOFLEX branded products,

In addition, DS Group is pleased to announce the appointment of Kipton Lade as CEO. Kipton is a seasoned professional specializing in driving business scalability and profitable growth for top-tier corporations through strategic key account management, sales, marketing, and product management. He has a proven track record in directing strategic commercialization and guiding companies through critical growth phases, consistently achieving substantial revenue growth, expanding customer bases, and revamping organizational offerings.


“My vision for Meditech International is to acknowledge and honor the company’s rich history while leveraging current relationships. I would like Meditech International make a significant contribution to the health and well-being of patients being treated with our BIOFLEX product lines, while building a world renowned, therapeutic laser business,” said Kipton Lade, CEO of Meditech International Inc.


About Meditech International
Meditech International Inc. initiated research into the development of Laser Therapy devices in 1989. Incorporating its patented, proprietary technology, Meditech designs, manufactures, markets and treats with the BioFlex Laser Therapy system.

The goal of the company is to engineer devices that are superior to those in existence and scientifically develop accurate, effective protocols to treat a variety of medical conditions in the musculoskeletal field. The company’s primary objective is to significantly improve the multiple pathologies it encounters in the shortest possible time. Guidelines to that effect consist of the elimination of pharmaceuticals and pain and the restoration of normal mobility and quality of life.

The company also conducts extensive clinical research with the objective of expanding the scope of application of these devices, particularly in conditions where current medical approaches are ineffective. Laser Therapy utilizing the BioFlex platform has been successfully utilized to treat a range of medical conditions relating to the musculoskeletal system, arthritis, sports injuries and wounds. For more information visit http://www.bioflexlaser.com

About DS Group
DS Group works with ambitious progressive growth minded entrepreneurs who want to get the most out of life and business. Entrepreneurs who value their team and collaborating to achieve results together that cannot be achieved by one person. DS Group provides you with a new perspective and the path forward in taking the next steps in scaling your business. DS Group collaborates with entrepreneurs to break through the barriers to reach the next level in the entrepreneur’s evolution.

PRESS RELATIONS
Kipton Lade
kipton@bioflexlaser.com

To top